4 June 2026 | Price: $3.13 (Jun 3 close) | Position: none — this is an AVOID | Market cap: ~$120M
Laser Photonics is a Lake Mary, Florida micro-cap that makes industrial laser cleaning and laser-blasting systems. On June 3 it traded 224 million shares — roughly 35x its 30-day average — and closed up 29% at $3.13, capping a +336% one-month run, after announcing that its "Laser Shield" anti-drone system was selected by the Department of Defense under a Mission Engineering Initiative. Four months ago, on February 6, the same stock printed an all-time low of $0.38. The bull narrative is defense + counter-drone + a Johnson & Johnson order — a tidy 2026 thematic cocktail. The problem is what sits underneath the narrative: a company with negative shareholders' equity, an explicit going-concern opinion from its own auditor, $650K of cash against a $5M-a-quarter burn, a share count that nearly tripled in 17 months, and a Nasdaq deficiency notice for failing to file its Q1 2026 10-Q. In God we trust; everyone else brings data. So let's bring the data, both sides, honestly.
FY2025 revenue hit $8.34M, up from $3.42M in FY2024 — a genuine +144% jump. After three years stuck around $3.9M, something moved. If you squint, this is a company finding commercial traction in laser cleaning for industrial and defense maintenance.
A pre-revenue-scale company suddenly name-dropping the DoD and J&J in the same fortnight is exactly the kind of narrative that moves a thin micro-cap hundreds of percent.
Director Lu Qing bought ~218,000 shares at $0.61–$0.79 in late April 2026 — after selling a much smaller ~32K at $0.98 days earlier. Net, that's a real directional open-market buy near the bottom, the one insider signal that costs the buyer their own money ([shr-002]).
Short interest is only 5.35% of float and 0.81 days to cover (May 15). Whatever this move is, it isn't shorts being squeezed — there's no big bearish position to trap. (For a bull, the absence of an obvious short wall means the rally isn't a mechanical short squeeze that has to unwind.)
The FY2025 10-K (filed April 20, 2026) carries an explicit going-concern opinion: language raising "substantial doubt about the Company's ability to continue as a going concern." This is not analyst opinion. This is the company's own audited filing.
| Balance sheet (Dec 31, 2025) | Value |
|---|---|
| Cash & equivalents | $0.65M |
| Total debt | $8.92M |
| Stockholders' equity | –$5.04M (negative) |
| Working capital | –$7.34M |
| Current ratio | 0.29 |
| Q4 2025 operating cash burn | –$4.96M in one quarter |
The company ended 2025 with negative book value and essentially no cash, against a burn rate that would exhaust that cash in weeks, not quarters. P/B is meaningless because book value is negative. It has never been profitable since its 2022 IPO.
The share count went from 14.3M (Dec 2024) → 22.8M (Dec 2025) → 38.6M (May 2026) — nearly tripling in 17 months. The mechanism is a self-perpetuating warrant cascade:
Known warrant overhang from A-3 through A-6 plus placement-agent warrants alone is ~14.7M shares — ~38% of shares outstanding — and every one is deep in the money at $3.13. There is no formal ATM, but this is structurally worse: a price-adaptive machine that lowers the strike to induce cash exercises, then issues more warrants each time. Every rally is the fuel for the next wave of selling. This is the "dilute-and-replace" pattern my playbook flags as an avoid-entirely structure ([shr-025], [shr-022], [shr-037], [shr-039]).
| FY2023 | FY2024 | FY2025 | |
|---|---|---|---|
| Revenue | $3.94M | $3.42M | $8.34M |
| Gross margin | 73.6% | 11.8% | 14.4% |
| Operating margin | –85% | –162% | –110% |
| Net income | –$3.3M | –$2.5M | –$17.5M |
Revenue doubled, but gross margin fell from 73.6% to ~14%, and Q4 2025 gross profit went outright negative (–$1.14M). They are selling more while losing money on each incremental sale. The –$17.5M net loss is ~2x the operating loss, implying large non-operating/non-cash charges (interest, warrant/derivative marks). This is not the profile of a business scaling toward profitability.
The Q1 2026 10-Q (period ended March 31) has not been filed. An NT 10-Q was filed May 15, and Nasdaq issued a deficiency notice on May 21, 2026. The CFO seat turned over twice (resignation Jan 8; a fractional CFO appointed May 7). A company that cannot produce financials on schedule, during the exact window it is raising the stock 300%, is a company you cannot underwrite.
At $3.13 and ~$120M market cap: P/S 14.4x on $8.3M of revenue, EV/EBITDA negative, P/B negative, no analyst coverage, no price targets, no estimates. You are paying a software-like multiple for an unprofitable, cash-out hardware micro-cap.
This is not a buy. It's a hard avoid. Not because the lasers don't work or the DoD headline is fake — but because the equity is the wrong instrument wrapped around them. The combination is the textbook trap:
The way micro-caps like this resolve is well-worn: the spike gives warrant holders and the controlling shareholder the liquidity to sell into, the new shares hit the float, and the price retraces toward the strike prices ($0.70–$1.08) where the dilution was set. The February low was $0.38. The structure that produced that low is still fully in place — only now there are far more warrants.
If you want the counter-drone / industrial-laser theme, express it through a financially solvent name, not a going concern that is monetizing its own stock spike. No position. No tranche. Nothing to time here — there's no fundamental floor to lean on, only a dilution ceiling to bump your head on.
Not investment advice. Micro-cap, high volatility, do your own work — but the data above is the work, and the data says stay away.